X4 Pharmaceuticals

$5.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.31 (+5.82%) As of 1:19 PM EDT today

Why Robinhood?

You can buy or sell XFOR and other stocks, options, and ETFs commission-free!

About XFOR

X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Read More Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA. The listed name for XFOR is X4 Pharmaceuticals, Inc. Common Stock.

CEO
Paula S. Ragan, PhD
Employees
58
Headquarters
Cambridge, Massachusetts
Founded
2010
Market Cap
93.26M
Price-Earnings Ratio
Dividend Yield
Average Volume
78.81K
High Today
$5.77
Low Today
$5.41
Open Price
$5.46
Volume
55.47K
52 Week High
$15.00
52 Week Low
$5.38

Collections

XFOR Earnings

-$0.83
-$0.55
-$0.28
$0.00
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Estimated
per share
Actual

You May Also Like